The sale of FibroGen China to AstraZeneca PLC simplifies the company's operations and cleans up its balance sheet, CEO Thane ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

AstraZeneca walked away from the bulk of its roxadustat partnership with FibroGen—though the pharma at the time decided to ...

AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Clearside Biomedical (CLSD) reported that Arctic Vision’s New Drug Application or NDA for arcatus for the treatment of uveitic macular edema ...

China’s economy has grown impressively over the past several decades. It is now unquestionably the world’s second largest, and it has become far more innovative than it once was. But it is not nearly ...

A huge statue of Mao Zedong still stands near the entrance to Zhejiang University, surveying the transformation of the ...

We remain optimistic about Australian healthcare investments, with key trials and FDA approvals expected in 2025, potentially ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.